Halozyme Therapeutics
HALO
#2394
Rank
NZ$10.69 B
Marketcap
$84.09
Share price
0.81%
Change (1 day)
42.20%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of September 2024 : NZ$1.17 Billion

According to Halozyme Therapeutics's latest financial reports the company has NZ$1.17 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.53 B-7.02%
2022-12-31NZ$0.57 B-47.32%
2021-12-31NZ$1.08 B112.68%
2020-12-31NZ$0.51 B-18.46%
2019-12-31NZ$0.62 B18.35%
2018-12-31NZ$0.52 B-20%
2017-12-31NZ$0.66 B123.26%
2016-12-31NZ$0.29 B86.94%
2015-12-31NZ$0.15 B-8.55%
2014-12-31NZ$0.17 B98.93%
2013-12-31NZ$87.01 M-28.06%
2012-12-31NZ$0.12 B78.7%
2011-12-31NZ$67.68 M-37.28%
2010-12-31NZ$0.10 B16.18%
2009-12-31NZ$92.88 M-15.4%
2008-12-31NZ$0.10 B-13.9%
2007-12-31NZ$0.12 B103.3%
2006-12-31NZ$62.72 M124.08%
2005-12-31NZ$27.99 M24.77%
2004-12-31NZ$22.43 M2795.89%
2003-12-31NZ$0.77 M316.9%
2002-12-31NZ$0.18 M195.33%
2001-12-31NZ$0.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.44 B-62.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.22 B 428.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.51 B 113.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.60 B 1,393.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.88 B 993.21%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$35.90 B 2,946.20%๐Ÿ‡บ๐Ÿ‡ธ USA